United States: Weekly Washington Healthcare Update: April 22, 2013

Last Updated: April 25 2013
Article by Stephanie A. Kennan and Brian J. Looser

Highlights This Week: Committee hears from FDA on drug compounding incident...GOP Senators questions health information technology policies...Arkansas passes privatized Medicaid expansion, awaits decision from HHS Secretary Sebelius.

1. CONGRESS

House of Representatives

Energy and Commerce Hearing on Drug Compounding Regulation

On Tuesday, the Energy and Commerce Committee held a hearing in which Food and Drug Administration Commissioner Margaret Hamburg testified as to her agency's role in overseeing the activities of the New England Compounding Center (NECC) in the years leading up to the deadly fungal meningitis outbreak last fall. Members on both sides of the aisle criticized the FDA's lack of activity in preventing the spread of contaminated drugs, which has led to the deaths of more than 50 people; however, some Democrats noted that the FDA's authority over compounding clinics in some areas is unclear, due to a patchwork of state and federal laws and conflicting court decisions. Republicans took the opportunity to unveil a report criticizing the FDA's decision to suspend inspections of the NECC facility, instead choosing to clarify its policy on compounder regulation. The Senate HELP Committee is expected to release on Friday a draft of legislation aimed at bolstering oversight of compounding pharmacies.

McDermott Asks CMS to Close Fraud Loophole

Last week, Rep. McDermott wrote a letter asking CMS to address concerns he has with current regulations related to Medicare's ability to combat fraud. Specifically, McDermott points to several court cases in which Medicare providers have been found to be in violation of portions of the Code of Federal Regulations (CFR) related to "conditions of enrollment," though no sanctions are imposed under the False Claims Act (FCA) because only violations of "conditions of payment" can trigger such sanctions. "I am concerned that the Medicare trust fund has lost hundreds of millions of dollars when several False Claims Act ('FCA') decisions won by federal prosecutors have been overturned on this basis," McDermott wrote.

Dual-Eligible Drug Rebate Legislation Introduced

Legislation has been introduced in both the House and Senate that would require pharmaceutical companies to provide rebates for drugs for people who qualify for both Medicare and Medicaid, known as "dual-eligibles." Under the bill, drug manufacturers would pay a rebate based on the lowest current rebate they pay to Medicare Part D plans and their current Medicaid average manufacturer price (AMP) percentage. Sen. Rockefeller (D-WV) is the lead sponsor in the Senate, while House Energy and Commerce Committee Ranking Member Waxman (D-CA) introduced the House companion. Drug makers, who oppose the bill, claim the proposal would raise premiums and copays and would lead to restricted access to medicines for low-income seniors and other vulnerable populations.

Sebelius Testifies in Health Subcommittee on FY2014 Budget Request

On Thursday, the House Energy and Commerce Committee held a hearing titled "A Financial Review of the Department of Health and Human Services and Its FY 2014 Budget," in which HHS Secretary Sebelius appeared to testify. The hearing focused on President Obama's proposed FY2014 budget request for HHS, as well as the department's activities related to implementation of the 2010 health reform law.

Witnesses:
The Honorable Kathleen Sebelius
Secretary
U.S. Department of Health and Human Services

For more information, or to view the hearing, please visit: energycommerce.house.gov.

Committee Passes High-Risk Pool Bill; House Vote Scheduled

Last week, the Energy and Commerce Committee approved legislation that would authorize funding for a program created by the Affordable Care Act (ACA), which would be responsible for assisting individuals with pre-existing conditions to acquire health insurance. The bill, H.R. 1549, would transfer funds from the ACA's Prevention and Public Health Fund, which has been derided by Republicans as a slush fund for the Administration, in order to fund the Pre-Existing Condition Insurance Plan (PCIP). In addition, the bill would remove an existing requirement that individuals be uninsured for six months in order to qualify for PCIP. While the committee approved the bill along party lines, Democrats offered an amendment that would have changed the bill's funding source, indicating that the use of Prevention and Public Health Fund dollars was a chief source of concern. The bill is expected to receive full House consideration this week.

Senate

Meaningful Use and Health Information Technology Questions

Several Republican senators have released a paper highlighting flaws they see in the 2009 stimulus bill's health information technology (HIT) initiatives, claiming increased health care costs and concerns over patient privacy as a result of the policies. The paper, entitled "Reboot!: Re-examining the Strategies Needed to Successfully Adopt Health IT," authored by Sens. Thune (R-ND), Alexander (R-TN), Roberts (R-KS), Burr (R-NC), Coburn (R-OK) and Enzi (R-WY), outlines perceived problems related to the implementation of the Health Information Technology for Economic and Clinical Health (HITECH) Act, including concerns over the ability of providers to achieve "meaningful use" of HIT, as required by the law. In addition, the group wrote a letter to HHS Secretary Sebelius asking that she answer a list of questions related to the concerns outlined by their white paper.

2. ADMINISTRATION

CMS

Tavenner Response to Finance Confirmation Written Questions

Following her notably smooth confirmation hearing, in which no member of the Senate Finance Committee voiced opposition to her nomination, CMS Acting Administrator Tavenner last week responded in writing to Questions for the Record (QFRs) by committee members. Questions covered topics including the agency's plan to engage the public to provide information related to health insurance exchanges, demonstrations and pilots being conducted by the Center for Medicare and Medicaid Innovation (CMMI), and the overall cost of operating federally facilitated exchanges (FFEs). Tavenner also confirmed that President Obama was intent on advancing the nomination process for members of the Independent Payment Advisory Board (IPAB).

Timeline for Basic Health Plan (BHP) Released

Sen. Maria Cantwell has posted a simple chart on her website offering a timeline for implementation of the Basic Health Plan (BHP), provided for by the ACA. BHP is an optional coverage program under the ACA that allows states to use federal tax subsidy dollars to offer subsidized coverage for certain low-income individuals. The timeline begins with currently ongoing discussions among HHS and stakeholders, with the program becoming operational Jan. 1, 2015. Cantwell had previously expressed concern about supporting the confirmation of CMS Acting Administrator Tavenner unless HHS focused on implementing BHP.

Food and Drug Administration (FDA)

Generic OxyContin Application Denied

On Tuesday, the FDA announced it would not approve a generic version of the opioid painkiller OxyContin because of the increased potential for abuse that accompanies doses of the compound absent crush-resistant formulas. Specifically, the FDA has determined that the benefits of original OxyContin no longer outweigh its risks and that original OxyContin was withdrawn from sale for reasons of safety or effectiveness. Accordingly, the agency will not accept or approve any abbreviated new drug applications (generics) that rely upon the approval of original OxyContin. The FDA, together with other public health agencies, continues to encourage the development of abuse-deterrent formulations of opioids and believes that such products will help reduce prescription drug abuse.

3. STATE ACTIVITIES

Arkansas Medicaid Waiver Passes State Legislature

Last week, Arkansas successfully advanced a plan championed by Gov. Beebe that would allow for an expansion of the state's Medicaid program, pursuant to the ACA, using federal dollars to purchase private insurance for the newly eligible population. However, the plan would require approval from HHS Secretary Sebelius in order to be operational. Though Sebelius has publicly acknowledged she's open to reviewing the proposal, approval could inspire other states to examine similar ways to leverage generous federal contributions without being accused of embracing the controversial health reform law.

Rhode Island Posts 2014 Health Insurance Premium Rates

Rhode Island has become one of the first states to publicly release rates for health insurance premiums for 2014. The list includes submissions from plans including Blue Cross Blue Shield of Rhode Island and United Healthcare, which will be reviewed by Rhode Island Health Insurance Commissioner Christopher Koller, who is expected to approve, modify or reject the requested rates by June 2013.

4. REGULATIONS OPEN FOR COMMENT

CMS Releases Health Exchange Navigator Rule

CMS issued a proposed rule that would create conflict-of-interest, training and certification, and meaningful access standards applicable to Navigators and non-Navigator assistance personnel in federally facilitated exchanges, including state partnership exchanges, and to non-Navigator assistance personnel in state-based exchanges that are funded through federal exchange establishment grants. These proposed standards would help ensure that Navigators and non-Navigator assistance personnel will be fair and impartial, will be appropriately trained, and will provide services and information in a manner that is accessible.

The proposed regulations would also make two amendments to the existing regulation for Navigators that would apply to all Navigators in all Affordable Insurance Exchanges (Exchanges), including State-based Exchanges, clarifying that any Navigator licensing, certification or other standards prescribed by the state or Exchange must not prevent the application of the provisions of Title I of the Affordable Care Act; and adding to the list of entities ineligible to become Navigators those entities with relationships to issuers of stop-loss insurance, including those who are compensated directly or indirectly by issuers of stop-loss insurance in connection with enrollment in Qualified Health Plans or non-Qualified Health Plans. The proposed regulations would also clarify that the same ineligibility criteria that apply to Navigators would also apply to non-Navigator assistance personnel providing services in any Federally facilitated Exchanges, including in State Consumer Partnership Exchanges, and to federally funded non-Navigator assistance personnel in State-based Exchanges. Comments on the proposed rule are due by May 6.

Charitable Hospital Rule

CMS has announced a proposed rule providing guidance to charitable hospital organizations on the community health needs assessment (CHNA) requirements, and related excise tax and reporting obligations enacted as part of the Patient Protection and Affordable Care Act of 2010. The proposed regulation also clarifies the consequences for failing to meet these and other requirements for charitable hospital organizations. These regulations will affect charitable hospital organizations.

Comments and requests for a public hearing must be received by July 1.

CMS Proposed Rule Would Increase Oversight of Accrediting Organizations

CMS has issued a proposed rule that would revise the survey, certification and enforcement procedures related to CMS oversight of national accreditation organizations (AOs). These revisions would implement certain provisions under the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA). The proposed revisions would also clarify oversight of AOs that apply for, and are granted, recognition and approval of an accreditation program in accordance with the Social Security Act. According to the proposed rule, health care facilities, with the exception of kidney transplant centers, end-stage renal dialysis facilities and providers of medical equipment and supplies, can demonstrate their compliance with Medicare conditions of participation, conditions of certification or conditions of coverage by being accredited by a CMS-approved organization. The proposed rule would implement, among other things, provisions requiring prospective or existing accreditation organizations seeking CMS approval of their programs to submit documentation proving they are a national accreditation organization, defined as an organization that accredits health care facilities under a specific program and whose accredited health care facilities under each program are widely located geographically across the United States. Comments on the proposed rule are due June 4.

IRS, HHS, DOL Issue Proposed Health Coverage Waiting Periods Rules

Under proposed rules issued jointly by the Internal Revenue Service, the Department of Labor's Employee Benefits Security Administration and the Department of Health and Human Services, no group health plan or group health insurance issuer could impose a waiting period that exceeds 90 days after employment. The rules also would amend regulations to conform to ACA provisions already in effect, as well as those that will become effective beginning in 2014, barring discrimination against people with pre-existing medical conditions. Comments are due by May 20.

FDA Proposed Rule on Defibrillator Premarket Approval Applications

The FDA filed notice of of a proposed rule to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the following class III preamendment devices: automated external defibrillators systems (AEDs), which include the AED device and its accessories (i.e., pad electrodes, batteries and adapters). The Agency is also summarizing its proposed findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring this device to meet the statute's premarket approval requirements and the benefits to the public from the use of the device. In addition, FDA is announcing the opportunity for interested persons to request that the Agency change the classification of the AED based on new information. This action implements certain statutory requirements. Comments will be accepted until June 20.

Proposed Rule for Part A Payment Appeals

On March 13, CMS issued a proposed rule that would allow CMS to pay for additional hospital inpatient services under Medicare Part B after it was denied under Part A because the beneficiary should have been treated as an outpatient. According to CMS, the rule would result in a $4.8 billion decrease in Medicare program expenditures over five years. The proposed rule will be published in the March 18 Federal Register, and comments are due May 17. Additionally, CMS Administrator Marilyn Tavenner issued an Administrator's Ruling to address the number of appeals of Part A hospital inpatient reasonable and necessary denials. The ruling sets a standard process for pending appeals and billing for the additional Part B inpatient services while the proposed rule is vetted.

CMS Request for Information (RFI) on Health Information Technology

CMS and the Office of the National Coordinator for Health Information Technology released a request for information last week on a number of options to further push the exchange of health information. Suggested options include requiring or encouraging Medicare ACOs to include health information exchange components, requiring health information exchange components in care models for dual eligibles and promoting the use of "Blue Button," which is a way for consumers to securely access their health information.

FDA Draft of Risk-Benefit Plan Published

The FDA filed a draft of its five-year plan for developing and implementing a benefit-risk framework that will guide its review of drugs. The notice was provided for in last year's prescription drug user fee agreement. Drug companies and some patient advocates have argued that FDA is overly concerned with risks that the market is willing to bear. FDA agreed to go through a public process of developing a framework that would factor those concerns into its review process.

HHS Interim Final Rule -- 2014 Notice of Benefit and Payment Parameters

HHS has issued an interim final rule with comment that builds upon standards set forth in the HHS Notice of Benefit and Payment Parameters for 2014. The interim final rule will adjust risk corridors calculations that would align the calculations with the single risk pool provision, and set standards permitting issuers of qualified health plans the option of using an alternate methodology for calculating the value of cost-sharing reductions provided for the purpose of reconciliation of advance payments of cost-sharing reductions. Comments are due by April 30, which is also when the rule becomes effective.

ACA's "Whistleblower" Protection Rule Proposed

DOL published an interim final rule that would implement the employee protection (whistleblower) provision of Section 1558 of the Affordable Care Act, to provide protections to employees of health insurance issuers or other employers who may have been subject to retaliation for reporting potential violations of the law's consumer protections (e.g., the prohibition on denials of insurance due to pre-existing conditions) or affordability assistance provisions (e.g., access to health insurance premium tax credits). The interim rule also establishes procedures and time frames for the handling of retaliation complaints, including procedures and time frames for employee complaints to the Occupational Safety and Health Administration (OSHA), investigations by OSHA, appeals of OSHA determinations to an administrative law judge (ALJ) for a hearing de novo, hearings by ALJs, review of ALJ decisions by the Administrative Review Board (ARB) (acting on behalf of the Secretary of Labor) and judicial review of the Secretary's final decision. Comments will be received until April 29, 2013.

DOL's press release

View the rule

Food and Drug Administration (FDA) Proposes New Food Safety Rules

The FDA has proposed new rules on food safety, including regulations on good manufacturing practices standards for growing, handling and packaging produce. Specifically, to minimize the risk of serious adverse health consequences or death from consumption of contaminated produce, the FDA is proposing to establish science-based minimum standards for the safe growing, harvesting, packing and holding of produce, meaning fruits and vegetables grown for human consumption. FDA is proposing these standards as part of its implementation of the FDA Food Safety Modernization Act (FSMA). These standards would not apply to produce that is rarely consumed raw, produce for personal or on-farm consumption, or produce that is not a raw agricultural commodity. The proposed rule would also set forth procedures, processes and practices that minimize the risk of serious adverse health consequences or death, including those reasonably necessary to prevent the introduction of known or reasonably foreseeable biological hazards into or onto produce and to provide reasonable assurances that the produce is not adulterated on account of such hazards.

Another proposed rule would amend FDA's current regulation for Current Good Manufacturing Practice In Manufacturing, Packing, or Holding Human Food (CGMPs), which requires domestic and foreign facilities that are required to register under the Federal Food, Drug, and Cosmetic Act (FD&C Act) to establish and implement hazard analysis and risk-based preventive controls for human food. FDA also is proposing to revise certain definitions in FDA's current regulation for Registration of Food Facilities to clarify the scope of the exemption from registration requirements provided by the FD&C Act for "farms."

Comments on both proposed rules are due by May 16, 2013.

5. REPORTS

HHS-OIG

Medicare Part D Prepayment Delay Could Have Earned Program $111 Million

According to a report issued April 16 by the HHS Office of the Inspector General (HHS-OIG), the Medicare Part D trust fund could have earned $111 million in calendar year 2009 if it had delayed prepayments to Part D plans by 20 days. The report, "Impact on Medicare Program for Investment Income That Medicare Part D Plans Earned and Retained From Medicare Funds in 2009," bases its conclusions on the potential interest income that could be achieved by a 20-day delay in plan prepayments, assuming that the federal government would have invested the prepayment money in interest-bearing financial instruments with annual interest rates of 4.4 percent, equal to what the Medicare Part D trust fund earned in 2009. The report recommends that CMS seek legislative action to delay prepayments to Part D plans, or implement regulations that require Part D plans to include expected interest income in their bid proposals. CMS disagreed with the OIG recommendations and said "the implementation of either option would cause most Part D plans to increase their bid proposals to recoup the investment income that they would lose."

Simpson-Bowles

New Simpson-Bowles Proposal Includes Chained CPI, Medicare Buy-In

The bipartisan duo of Alan Simpson and Erskine Bowles has released an updated set of deficit reduction proposals, focusing on major reforms to our nation's entitlement programs, including Social Security and Medicare. Overall, the plan calls for roughly $2.4 trillion in deficit reduction over 10 years, including $600 billion in additional revenues and $600 billion in health care savings, as well as an overhaul of the U.S. tax system. Specifically, Simpson and Bowles would achieve $585 billion in savings through health-related reforms including changes to Medicare's cost-sharing structure and increasing eligibility age for the program. In addition, the plan would reduce the deficit by $280 billion over the next 10 years by implementing a "chained" Consumer Price Index (CPI), which reflects a slower growth in inflation than the conventional CPI.

Bipartisan Policy Center

Proposal Claims $560 Billion in Health Care Savings

Last week, the Bipartisan Policy Center released its plan to reduce health care spending through a combination of reforms the authors claim will avoid politically toxic issues, such as having a premium support system for Medicare or raising the age of eligibility for Medicare. Led by former Sens. Daschle, Frist and Domenici, as well as budget expert Alice Rivlin, the proposal would achieve about $300 billion in Medicare savings over 10 years, and an additional $260 billion through adjustments to the tax code. Of note, the plan would prohibit first-dollar Medigap policies and increase Medicare means-testing for higher-income beneficiaries. It would also combine the Medicare Part A and B deductibles.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions